coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Chichester Alliance Of Medical Practices PCN, Chichester · Health Inequalities Profile

    PCN U24558 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    91,717

    Registered population

    54.5% aged 18–64

    28.1%

    Aged 65+

    ICB 21.9% · England 17.9%

    5.0%

    Ethnic minority (non-White)

    2.0% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    15,948

    Hypertension register

    +5.47% in 3 yrs · England +5.60%

    1,018

    SMI register

    83.6% of Chichester's

    1,799

    COPD register

    Reviews -4.82% in 3 yrs

    Forecast to 2030

    18,177

    Hypertension patients, 2030

    +2,229 on today

    70.9%

    QRISK ≥20% on statins, 2030

    +4.58pp over 3 yrs

    5.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    72.8%
    Hypertension control and recording exceed England.

    Hypertension treatment to target is 72.8% (Chichester 72.8%, ICB 69.1%, England 70.3%), with 92.6% having a recent blood pressure reading (England 90.0%).

    11
    Eleven three-year trends lag behind England.

    Across 25.0 measures, 11 trail England's three-year change, including heart failure reviews (-2.8%), COPD reviews (-4.8%), and smoking cessation support (-4.8 pp).

    6.4 pp
    Preschool second-dose MMR trails first dose.

    Age-five MMR coverage is 94.5% for dose 1 versus 88.1% for dose 2 (95.0% target), with a 16 pp difference at Parklands Surgery.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients represent 28.1% of the list, well above England's 17.9%

    The PCN registers 91,717 patients across eight practices. Older people form 28.1% of the list (25,781 patients), exceeding Chichester (26.9%), NHS Sussex Integrated Care Board (21.9%), and England (17.9%). Working-age adults (18–64) comprise 54.5% (Chichester 55.8%, ICB 60.5%, England 62.7%) and children (0–17) 17.4% (Chichester 17.3%, ICB 17.7%, England 19.6%). Census estimates show 95.0% White residents and 5.0% ethnic minority groups (Asian 2.0%), compared with Chichester (95.4%), the ICB (91.0%), and England (81.1%). Ethnicity reflects local resident Census estimates rather than registered GP records, and projected 2.1% growth to 2030 uses an unverified methodology.

    Age profile

    0–1717.4%
    18–6454.5%
    65+28.1%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White95.0%
    Asian2.0%
    Mixed1.7%
    Black0.7%
    Other0.6%

    Older people · falls rows are Chichester local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Chichester LA)2,4532,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Chichester LA)1,2859819552024/25
    Falls deaths, all ages, per 100,000 (Chichester LA)8.714.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    With 0.0% Core20 residence, clinical vulnerability in the PCN may be largely non-spatial

    The PCN records an average IMD decile of 6.1 (Chichester 6.2, NHS Sussex ICB 6.1, England 5.5), with 0.0% of registered patients living in Core20 areas (England 21.0%, NHS Sussex ICB 9.2%). Across member practices, Core20 share is 0.0%, while practice average IMD deciles range from 5.1 at Selsey Medical Practice to 7.4 at Southbourne Surgery. As area deprivation deciles may not capture pocket vulnerability, inequality efforts could prioritise non-spatial clinical cohorts, including 1,018 severe mental illness and 536 learning disability patients.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Langley House0.0% · 0 patients
    Selsey Medical0.0% · 0 patients
    Cathedral Medical0.0% · 0 patients
    Parklands0.0% · 0 patients
    Lavant Road0.0% · 0 patients
    Tangmere0.0% · 0 patients
    Southbourne0.0% · 0 patients
    Witterings0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,018

    SMI register

    1.10% recorded prevalence

    536

    Learning disability register

    0.58% recorded prevalence

    46

    Care homes, 1,656 beds

    In the PCN catchment

    8.5%

    Provide unpaid care

    Chichester, Census 2021

    The PCN records 1,018 severe mental illness patients (1.1%) and 536 on the learning disability register (0.6%), comprising 83.6% and 81.8% of Chichester's totals. The catchment contains 46 care homes with 1,656 beds. Chichester district recorded an 8.5% unpaid care rate and 9 rough sleepers in 2025.

    Severe mental illness: physical health checks

    SMI blood pressure recording reached 83.0% (England 83.4%) and BMI checks 83.1% (England 82.1%), but smoking cessation support fell 4.8 pp over three years (England +0.1 pp) to 87.1% (England 94.2%). Missing elements cannot imply completed checks.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    15,948

    Hypertension register

    +5.47%

    Register growth, 3 yrs

    Chichester +5.87% · England +5.60%

    +3.18pp

    BP control, under 80

    ≤140/90 · +1.90pp aged 80+

    +2,229

    More patients by 2030

    Forecast 18,177 (19.14%)

    Hypertension case-finding and control

    The PCN records 15,948 patients on its hypertension register, a crude prevalence of 17.2%, compared with 17.4% in Chichester, 16.3% in NHS Sussex ICB, and 15.2% in England. Practice prevalence ranges from 11.6% at Parklands Surgery and 14.3% at Lavant Road Surgery to 23.4% at Selsey Medical Practice. Over three years, prevalence rose +5.5% (+0.9 pp), matching NHS Sussex ICB (+5.5%) and near England (+5.6%). Process measures show 92.6% of patients have a recent blood pressure reading (England 90.0%) and 72.8% are treated to target (England 70.3%). Crude prevalence is unadjusted for age. Treatment to target above England is consistent with strong clinical control; recorded practice differences do not establish under-detection and remain untested locally.

    Lipids and statins

    Among patients with QRISK ≥ 20%, 60.6% receive lipid-lowering therapy, compared with 60.4% in Chichester, 60.0% in NHS Sussex ICB, and 63.6% in England, despite +8.2% three-year growth. Coverage trailing England could reflect recall or initiation gaps, which would require practice audit to confirm.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026216,466£2.10£2.42£1.86£454,579
    Cardiovascular (all), 2025269,323£2.98£3.32£3.33£802,583

    In 2026, the PCN prescribed 216,466 lipid-modifying items at £2.10 each (Chichester £2.11, NHS Sussex ICB £2.42, England £1.86), spending £51,952 more than at England's unit cost. Unit cost does not reflect treatment appropriateness. Higher unit costs than England could reflect formulary choices, though unit cost does not establish prescribing efficiency or treatment appropriateness.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.69%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.07%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.9% (1,799 patients), matching England (1.9%), but 12-month reviews fell 4.8% over three years to 75.5% (England +2.8%). Asthma prevalence is 7.5% (6,644 patients; England 6.6%), with reviews rising +5.7% (England +4.4%) to 68.5% (England 65.7%). Applying this rate across the register leaves an estimated scale gap of about 2,100 (2,094) unreviewed asthma patients. Prescribing reached 1,751 items per 1,000 aged 5-19 (England 1,488). Divergent review trends could reflect differing recall prioritisation, untested locally.

    Cancer register and children's immunisation

    Cancer prevalence is 5.1% (4,694 patients), above England (3.8%). In childhood immunisations, 6-in-1 complete course at 24 months reached 95.3% (NHS Sussex ICB 92.9%). However, age-five MMR dose 2 coverage is 88.1% (sitting 6.9 pp below the 95.0% target), creating a 6.4 pp difference from dose 1 (94.5%). The 4-in-1 booster reached 87.2% (sitting 7.8 pp below the 95.0% target). Dose attrition could reflect recall timing gaps, untested locally.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.7%

    England 91.0%

    6-in-1 complete primary course at 24 months95.3%

    England 92.2%

    MMR dose 1 at 24 months93.5%

    England 88.3%

    MMR dose 2 at age 588.1%

    England 82.8%

    4-in-1 pre-school booster at age 587.2%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, exceeding England (55.3%) but sitting 16.5 pp below the 75.0% national ambition by 2028. Closing this gap requires about 1,360 additional early-stage diagnoses annually across the ICB. Staging completeness was 64.3% (8,209 of 12,766 registered cancers; England 67.0%). Within the PCN, cervical screening coverage for women aged 25 to 49 is 71.1% (England 66.8%), but falls to 57.0% at Cathedral Medical Group. Lower cervical screening uptake at specific practices may indicate non-responder follow-up gaps that could be tested through practice audit.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At University Hospitals Sussex NHS Foundation Trust, distance to the 85.0% 62-day referral to treatment standard is -19.8 pp, distance to the 96.0% 31-day combined treatment standard is -19.2 pp, and distance to the 75.0% 28-day faster diagnosis standard is -1.0 pp. For NHS Surrey and Sussex Integrated Care Board, distance to the 62-day standard is -13.5 pp, distance to the 31-day standard is -5.6 pp, and distance to the 28-day standard is 4.3 pp. These measures capture hospital and system pathway pressures rather than PCN referral volume.

    Pathways within standard (%)SussexPortsmouthSouthamptonSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0166.8175.0779.2979.32
    31-day treatment (96%)76.7994.7886.7690.4592.50
    62-day referral to treatment (85%)65.2075.2074.4471.5171.16
    Diagnostic waits over 6 weeks (%)SussexPortsmouthSouthamptonEngland
    MRI5.6250.3614.3021.40
    CT8.5713.0616.479.92
    Echocardiography0.3932.7514.5828.48
    Colonoscopy39.3582.5215.8430.83
    Gastroscopy20.0274.8818.4729.02
    All 15 DM01 tests12.9551.9620.8423.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In the provisional June 2026 Community Services Dataset, 72.7% of all contacts with Chichester local authority residents were for adults aged 65 and older (56,740 of 78,050 contacts). This concentration reflects community health delivery across the wider local authority population rather than PCN-specific activity, indicating high local dependence on community and intermediate care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    High QOF domain achievement does not establish complete population reach across member practices

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Langley House1010.070.9%80.3%87.5%
    Tangmere990.081.1%81.0%82.9%
    Parklands Surgery1070.057.1%70.4%78.4%
    Witterings1300.044.3%64.8%77.1%
    Selsey Medical1530.040.9%61.7%74.8%
    Cathedral Medical1130.041.2%79.9%74.1%
    Lavant Road1000.043.5%75.8%69.4%
    Southbourne1140.021.6%77.7%67.2%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNChichesterAssetPCNChichester
    Care homes (catchment)46 (1,656 beds)n/aSchools (catchment)74n/a
    Children's centres56Places of worship91153
    Libraries45Homelessness support (VCS)0no data
    Day centres (VCS)11Carers support groups (VCS)11
    Primary schools (LA maintained)1631Primary academies2022
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Preschool second-dose MMR recall

    Age-five MMR coverage drops 6.4 pp from dose 1 (94.5%) to dose 2 (88.1%, cohort 218), sitting 6.9 pp below the 95.0% target. For discussion: practices could audit age-five cohorts missing a second MMR dose and align recall prompts with pre-school booster invitations. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Chronic review and smoking recall

    Three-year changes trail England across 11 of 25 measures, including smoking support (-4.8 pp vs +0.1 pp, at 87.1% vs 94.2%), heart failure (-2.8% vs +8.7%), and COPD reviews (-4.8% vs +2.8%). Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Structured annual asthma review recall

    With 68.5% of the 6,644 asthma register recorded as reviewed in 12 months (England 65.7%, Chichester 67.5%, ICB 62.5%), an estimated scale gap of 2,094 (about 2,100) patients remains. For discussion: practices could pair inhaler prescribing checks with standardised annual review invitations and flexible clinic slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frailty and multi-morbidity service planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Non-spatial inclusion health outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation recall audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension case-finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Option 1 · Preschool second-dose MMR recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Chronic review and smoking recall (p12)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs) · Patients with heart failure who had a review in the last 12 months including the assessment of functional capacity (denominator incl. PCAs) · Patients with COPD who had a review in the last 12 months (denominator incl. PCAs)Core20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Structured annual asthma review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15